Publications by authors named "T J Tucker"

The genetic information that dictates the structure and function of all life forms is encoded in the DNA. In 1953, Watson and Crick first presented the double helical structure of a DNA molecule. Their findings unearthed the desire to elucidate the exact composition and sequence of DNA molecules.

View Article and Find Full Text PDF

Racial differences in healthcare access (HCA) may contribute to disparities in ovarian cancer (OC) survival. We used structural equation models (SEM) to examine associations between race and HCA domains (affordability, availability, accessibility) in relation to overall and OC-specific mortality. Non-Hispanic (NH)-Black and non-Black (Hispanic, NH-White) women diagnosed with OC in 2008-2015 were identified from SEER-Medicare.

View Article and Find Full Text PDF
Article Synopsis
  • The introduction discusses the concerns surrounding the use of disease-modifying therapies for Alzheimer's disease, such as their clinical benefits, risks, costs, and the hesitation of clinicians to prescribe them.
  • The study compares lecanemab, an anti-amyloid therapy for Alzheimer's, with four other biologic agents used in various diseases, focusing on their costs, benefits, and risks.
  • Results indicate that the costs, clinical benefits, and safety of anti-amyloid therapies are similar to those of the other biologics, suggesting a promising future for Alzheimer's treatments.
View Article and Find Full Text PDF

Accurate assessment of fragment abundance within a genome is crucial in clinical genomics applications such as the analysis of copy number variation (CNV). However, this task is often hindered by biased coverage in regions with varying guanine-cytosine (GC) content. These biases are particularly exacerbated in hybridization capture sequencing due to GC effects on probe hybridization and polymerase chain reaction (PCR) amplification efficiency.

View Article and Find Full Text PDF

Importance: US cancer diagnoses were substantially lower than expected during the COVID-19 pandemic in 2020. A national study on the extent to which rates recovered in 2021 has not yet been conducted.

Objective: To examine observed vs expected cancer rate trends for January 2020 to December 2021.

View Article and Find Full Text PDF